| Bioactivity | Pyridoxylamine is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions. | ||||||||||||
| Invitro | Pyridoxylamine (PM), a member of the B6 vitamer family, is a potent scavenger of reactive carbonyls, inhibiting the late stages of glycation reactions that lead to AGE formation[1]. | ||||||||||||
| Name | Pyridoxylamine | ||||||||||||
| CAS | 85-87-0 | ||||||||||||
| Formula | C8H12N2O2 | ||||||||||||
| Molar Mass | 168.19 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Pyridoxylamine
CAS: 85-87-0 F: C8H12N2O2 W: 168.19
Pyridoxylamine is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.